Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population.
Kristina S BoyeFady T BotrosAxel HauptBrad WoodwardMaureen J LagePublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
Eli Lilly and Company.